Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
SPRYCompany Name
ARS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQARS PHARMACEUTICALS INC - Enterprise Value over EBIT Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SPRY - EV/EBIT Historical data
| Date | Earning Before Interest & Taxes (EBIT) | Enterprise Value | Enterprise Value over EBIT |
|---|---|---|---|
| 6/30/2025 | $ -47.73M | $ 1.59B | 0 |
| 3/31/2025 | $ -15.36M | $ 1.22B | 0 |
| 12/31/2024 | $ 8.29M | $ 1.42B | 171.7 |
| 9/30/2024 | $ -49.1M | $ 1.33B | 0 |
| 6/30/2024 | $ -44.84M | $ 911.62M | 0 |
| 3/31/2024 | $ -49.7M | $ 796.89M | 0 |
| 12/31/2023 | $ -54.37M | $ 797.82M | 0 |
| 9/30/2023 | $ -19.95M | $ 269.07M | 0 |
| 6/30/2023 | $ -22.95M | $ 536M | 0 |
| 3/31/2023 | $ -25.01M | $ 652.76M | 0 |
Key Performance Insights, Last 5 Years
- ARS PHARMACEUTICALS INC's latest trailing twelve months (TTM) EV/EBIT stands at 0.
- Over the past 5 years, ARS PHARMACEUTICALS INC's average EV/EBIT has been 171.7.
- The median EV/EBIT for ARS PHARMACEUTICALS INC during this period was 171.7
- ARS PHARMACEUTICALS INC reached its highest EV/EBIT over the past 5 years at 171.7.
- The lowest EV/EBIT recorded by ARS PHARMACEUTICALS INC in the same timeframe 171.7
ARS PHARMACEUTICALS INC's EV/EBIT vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV/EBIT Benchmarks
Similar metrics to EV/EBIT:
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Earning Before Interest & Taxes (EBIT) - [Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
Definition of Enterprise Value over EBIT
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].EV / EBIT
(=) EV/EBIT EV/EBIT for ARS PHARMACEUTICALS INC is calculated as follows: EV [ $ 0 ] / EBIT [ $ -23.97M ]
(=) EV/EBIT [ 0 ] SPRY - Enterprise Value over EBIT, Last 5 years
171.7
Minimum
Dec 31, 2024
171.7
Maximum
Dec 31, 2024
171.7
Average
171.7
Median
EV/EBIT Benchmark AnalysisMarket
The chart above depicts the distribution of EV/EBIT for companies in the Total Stock Market. The average EV/EBIT of the companies is 19.91 with a standard deviation of 12.32.
The following table provides additional summary stats:
EV/EBIT in the Market:
| filtered constituents | 2.25K |
|---|---|
| min | 0.05 |
| max | 62.03 |
| average | 19.91 |
| median | 16.78 |
| std | 12.32 |